VT News
Tadahito Iguchi

Tadahito Iguchi

Ask VT AI
View News Summary
  • Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
  • Thailand and Cambodia sign ceasefire at ASEAN summit, brokered by U.S. President Trump, but analysts warn of political and technical hurdles.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
  • Thailand and Cambodia sign ceasefire at ASEAN summit, brokered by U.S. President Trump, but analysts warn of political and technical hurdles.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Tadahito Iguchi

Top Topics

Trending in U.S.

World

Sport